CT organizations could learn a lot from practices of brand-new sites

March 2011
Clinical Trials Administrator;Mar2011, Vol. 9 Issue 3, p33
The article provides information on starting a new clinical trial (CT) site by highlighting the case of a successful site. Cindy Mendenhall, CCTA, clinical research coordinator at Evergreen Healthcare in Kirkland, Washington, offers an insight into the key aspects new CT sites should focus on. Ensuring adequate staffing and equipment, framing proactive standard operating procedures (SOPs), marketing, and developing a good budget, are suggested.


Related Articles

  • Expert provides list of basic SOPs for CT sites.  // Clinical Trials Administrator;Mar2011, Vol. 9 Issue 3, p34 

    The article presents the views of Cindy Mendenhall, CCTA, clinical research coordinator, Evergreen Healthcare, Kirkland, Washington, who provides a list of basic standard operating procedures (SOPs) for clinical trial (CT) sites. Included in the list are site selection/initiation visits,...

  • Managing CT offices: delegate and train.  // Clinical Trials Administrator;Aug2011, Vol. 9 Issue 8, p90 

    The article offers advice on how clinical trial sites can improve their management and documentation by delegating and training investigator and providing a narrative on documentation is a best practice. It also mentions that clinical research sites can develop their own quality assurance by...

  • Step out of your comfort zone to win a board role. Nebel, Andrew // Marketing (00253650);11/13/2003, p24 

    This article discusses the question of why marketing directors do not make it to the main board. The question appears to be frequently accompanied by two unspoken thoughts. The first seems to be the hand-wringing angst that in some way the corporate world is treating marketers cruelly and...

  • Create "recipes" of job roles.  // IRB Advisor;Mar2012, Vol. 12 Issue 3, p29 

    The article discusses long term improvements to be made for the future of institutional review board (IRB) offices, which include creation of a model to improve leadership succession, reduce staff turnover, and improve quality. It mentions the need to create sustainability and depth in IRB...

  • Good clinical practice in clinical trials: core knowledge for emergency physicians. Goodacre, Steve; Coats, Tim; Clancy, Michael // Emergency Medicine Journal;Dec2008, Vol. 25 Issue 12, p789 

    The article focuses on the significance of good clinical practice (GCP) in clinical trials. It says that GCP is a set of guidelines agreed at the International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use. It suggests that...

  • Cognitive behavioural therapy in mental health care. Johnson, Charlotte // Healthcare Counselling & Psychotherapy Journal;Jan2005, Vol. 5 Issue 1, p43 

    This article reports on the cognitive behavioural therapy which is high on the agenda of many psychological therapy services because of the recent NICE guidelines promoting it as the preferred treatment of choice for a range of psychological problems. This refreshing book presents a critique of...

  • European journal revises tumor size guidelines.  // Clinical Trials Administrator;May2009, Vol. 7 Issue 5, p59 

    This article announces the move by the "European Journal of Cancer," to revise its 2000 guidelines used to measure tumor size, called the Response Evaluation Criteria in Solid Tumors (RESIST). It mentions that clinical trial investigators use RECIST for phase II and phase III studies of new...

  • High tech tools build new concept of `market'. Yovovich, B. G. // Advertising Age;10/23/1995, Vol. 66 Issue 43, p29 

    The article stresses the need for marketing executives and companies in the U.S. to be ready for fundamental organizational changes that goes with information-driven marketing. One way to understand the scale of change that will be need is to look at the enormous advances that have been made in...

  • Substandard Data and Documentation Practices--Case Study #9. Pluta, Paul L.; Fields, Timothy J. // Journal of GXP Compliance;Spring2011, Vol. 15 Issue 2, p60 

    This article focuses on the validation process associated with manufacturing pharmaceutical products and medical devices. The sequence of activities involved in the process of validation are change desired, development work, validation plan, protocol, validation work, validation report,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics